Leukemia - Table of Contents alert Volume 31 Issue 8

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 31, Issue 8 (August 2017) In this issue Reviews Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Follow on Twitter Subscribe Advertisement Celebrating 30 years of Leukemia — 1987 to 2017 Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone. Watch our anniversary video showing a brief impact overview >>>   Reviews Top The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders N Maslah, B Cassinat, E Verger, J-J Kiladjian and L Velazquez Leukemia 2017 31: 1661-1670; advance online publication, May 9, 2017; 10.1038/leu.2017.139 Abstract | Full Text Why are hematopoietic stem cells so ‘sexy’? on a search for developmental explanation OPEN M Z Ratajczak Leukemia 2017 31: 1671-1677; advance online publication, May 15, 2017; 10.1038/leu.2017.148 Abstract | Full Text A revisionist history of adult marrow stem cell biology or ‘they forgot about the discard’ P Quesenberry and L Goldberg Leukemia 2017 31: 1678-1685; advance online publication, May 22, 2017; 10.1038/leu.2017.155 Abstract | Full Text Original Articles Top CHRONIC LYMPHOCYTIC LEUKEMIA IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus S Drennan, A D'Avola, Y Gao, C Weigel, E Chrysostomou, A J Steele, T Zenz, C Plass, P W Johnson, A P Williams, G Packham, F K Stevenson, C C Oakes and F Forconi Leukemia 2017 31: 1686-1694; advance online publication, November 28, 2016; 10.1038/leu.2016.356 Abstract | Full Text MULTIPLE MYELOMA, GAMMOPATHIES Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma S Mithraprabhu, T Khong, M Ramachandran, A Chow, D Klarica, L Mai, S Walsh, D Broemeling, A Marziali, M Wiggin, J Hocking, A Kalff, B Durie and A Spencer Leukemia 2017 31: 1695-1705; advance online publication, November 30, 2016; 10.1038/leu.2016.366 Abstract | Full Text RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response I J F Hofman, M van Duin, E De Bruyne, L Fancello, G Mulligan, E Geerdens, E Garelli, C Mancini, H Lemmens, M Delforge, P Vandenberghe, I Wlodarska, A Aspesi, L Michaux, K Vanderkerken, P Sonneveld and K De Keersmaecker Leukemia 2017 31: 1706-1714; advance online publication, December 2, 2016; 10.1038/leu.2016.370 Abstract | Full Text Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma J R Nair, J Caserta, K Belko, T Howell, G Fetterly, C Baldino and K P Lee Leukemia 2017 31: 1715-1726; advance online publication, December 23, 2016; 10.1038/leu.2016.379 Abstract | Full Text Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis F Gay, S Oliva, M T Petrucci, V Montefusco, C Conticello, P Musto, L Catalano, A Evangelista, S Spada, P Campbell, R Ria, M Salvini, M Offidani, A M Carella, P Omedé, A M Liberati, R Troia, A M Cafro, A Malfitano, A P Falcone, T Caravita, F Patriarca, A Nagler, A Spencer, R Hajek, A Palumbo and M Boccadoro Leukemia 2017 31: 1727-1734; advance online publication, December 23, 2016; 10.1038/leu.2016.381 Abstract | Full Text Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma M I da Silva Filho, A Försti, N Weinhold, I Meziane, C Campo, S Huhn, J Nickel, P Hoffmann, M M Nöthen, K-H Jöckel, S Landi, J S Mitchell, D Johnson, G J Morgan, R Houlston, H Goldschmidt, A Jauch, P Milani, G Merlini, D Rowcieno, P Hawkins, U Hegenbart, G Palladini, A Wechalekar, S O Schönland and K Hemminki Leukemia 2017 31: 1735-1742; advance online publication, December 27, 2016; 10.1038/leu.2016.387 Abstract | Full Text A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo OPEN S Hipp, Y-T Tai, D Blanset, P Deegen, J Wahl, O Thomas, B Rattel, P J Adam, K C Anderson and M Friedrich Leukemia 2017 31: 1743-1751; advance online publication, December 27, 2016; 10.1038/leu.2016.388 Abstract | Full Text STEM CELL TRANSPLANTATION Alloreactivity: the Janus-face of hematopoietic stem cell transplantation OPEN A Gratwohl, A Sureda, J Cornelissen, J Apperley, P Dreger, R Duarte, H T Greinix, E Mc Grath, N Kroeger, F Lanza, A Nagler, J A Snowden, D Niederwieser and R Brand for the European Society for Blood and Marrow Transplantation (EBMT) Leukemia 2017 31: 1752-1759; advance online publication, March 8, 2017; 10.1038/leu.2017.79 Abstract | Full Text MOLECULAR TARGETS FOR THERAPY Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma K T Siu, J Ramachandran, A J Yee, H Eda, L Santo, C Panaroni, J A Mertz, R J Sims III, M R Cooper and N Raje Leukemia 2017 31: 1760-1769; advance online publication, November 28, 2016; 10.1038/leu.2016.355 Abstract | Full Text Enhanced MAPK signaling is essential for CSF3R-induced leukemia S Rohrabaugh, M Kesarwani, Z Kincaid, E Huber, J Leddonne, Z Siddiqui, Y Khalifa, K Komurov, H L Grimes and M Azam Leukemia 2017 31: 1770-1778; advance online publication, December 27, 2016; 10.1038/leu.2016.376 Abstract | Full Text IMMUNOTHERAPY EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia OPEN S Charmsaz, F Al-Ejeh, T M Yeadon, K J Miller, F M Smith, B W Stringer, A S Moore, F-T Lee, L T Cooper, C Stylianou, G T Yarranton, J Woronicz, A M Scott, M Lackmann and A W Boyd Leukemia 2017 31: 1779-1787; advance online publication, December 6, 2016; 10.1038/leu.2016.371 Abstract | Full Text Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen OPEN S Rafiq, T J Purdon, A F Daniyan, M Koneru, T Dao, C Liu, D A Scheinberg and R J Brentjens Leukemia 2017 31: 1788-1797; advance online publication, December 7, 2016; 10.1038/leu.2016.373 Abstract | Full Text TRANSCRIPTIONAL CONTROL AND SIGNAL TRANSDUCTION, CELL CYCLE Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia W S Liau, S H Tan, P C T Ngoc, C Q Wang, V Tergaonkar, H Feng, Z Gong, M Osato, A T Look and T Sanda Leukemia 2017 31: 1798-1807; advance online publication, December 28, 2016; 10.1038/leu.2016.392 Abstract | Full Text PHARMACOLOGY The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies A Statler, T Radivoyevitch, C Siebenaller, A T Gerds, M Kalaycio, E Kodish, S Mukherjee, C Cheng and M A Sekeres Leukemia 2017 31: 1808-1815; advance online publication, December 7, 2016; 10.1038/leu.2016.374 Abstract | Full Text Letters to the Editor Top Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma S Knop, C Langer, M Engelhardt, L-O Mügge, A Reichle, W Rösler, F Bassermann, B Hertenstein, A Kunitz, C Röllig, H Ostermann, K Schäfer-Eckart, M Ringhoffer, A Günther, C Junghanss, H Biersack, M Schreder, A Liebert, S Held, H Einsele and R C Bargou for the Deutsche Studiengruppe Multiples Myelom (DSMM) Leukemia 2017 31: 1816-1819; advance online publication, April 25, 2017; 10.1038/leu.2017.124 Full Text Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia cluster OPEN G Cazzaniga, L Bisanti, G Randi, S Deandrea, S Bungaro, F Pregliasco, D Perotti, F Spreafico, G Masera, M G Valsecchi, A Biondi and M Greaves Leukemia 2017 31: 1819-1821; advance online publication, April 27, 2017; 10.1038/leu.2017.127 Full Text Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989–2015 M van der Meulen, A G Dinmohamed, O Visser, J K Doorduijn and J E C Bromberg Leukemia 2017 31: 1822-1825; advance online publication, April 28, 2017; 10.1038/leu.2017.128 Full Text No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden OPEN N Gunnarsson, M Höglund, L Stenke, F Sandin, M Björkholm, A Dreimane, M Lambe, B Markevärn, U Olsson-Strömberg, H Wadenvik, J Richter and A Själander Leukemia 2017 31: 1825-1827; advance online publication, May 2, 2017; 10.1038/leu.2017.131 Full Text Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome J R Schwartz, S Wang, J Ma, T Lamprecht, M Walsh, G Song, S C Raimondi, G Wu, M F Walsh, R B McGee, C Kesserwan, K E Nichols, B E Cauff, R C Ribeiro, M Wlodarski and J M Klco Leukemia 2017 31: 1827-1830; advance online publication, May 10, 2017; 10.1038/leu.2017.142 Full Text Targeting FLT3 by chimeric antigen receptor T cells for the treatment of acute myeloid leukemia L Chen, H Mao, J Zhang, J Chu, S Devine, M A Caligiuri and J Yu Leukemia 2017 31: 1830-1834; advance online publication, May 12, 2017; 10.1038/leu.2017.147 Full Text A critical role of periostin in B-cell acute lymphoblastic leukemia OPEN Z Ma, X Zhao, J Huang, X Jia, M Deng, D Cui, Z Du, G Fu, G Ouyang and C Xiao Leukemia 2017 31: 1835-1837; advance online publication, May 22, 2017; 10.1038/leu.2017.149 Full Text An unusual, activating insertion/deletion MPL mutant in primary myelofibrosis J-P Defour, Y Hoade, A-M Reuther, A Callaway, D Ward, F Chen, S N Constantinescu and N C P Cross Leukemia 2017 31: 1838-1839; advance online publication, May 22, 2017; 10.1038/leu.2017.153 Full Text Prognostic impact of IKZF1 deletions in association with vincristine–dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95 OPEN L Hinze, A Möricke, M Zimmermann, S Junk, G Cario, E Dagdan, C P Kratz, V Conter, M Schrappe and M Stanulla Leukemia 2017 31: 1840-1842; advance online publication, May 22, 2017; 10.1038/leu.2017.154 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.